| [1] |
Lin OS, Kozarek RA, Cha JM. Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies [J]. Intest Res, 2014, 12(4): 268-274.
|
| [2] |
Ng SC, Wong SH. Colorectal cancer screening in Asia [J]. Br Med Bull, 2013, 105: 29-42.
|
| [3] |
Ferlay J, Shin HR, Bray F,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127: 2893-2917.
|
| [4] |
宋彩霞，马强. 二甲双胍抑制结直肠肿瘤的相关机制研究进展[J]. 中国肿瘤临床, 2016, 43(22): 1012-1016.
|
| [5] |
Zhu N, Zhang Y, Gong YI, et al. Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis [J]. Biomed Rep, 2015, 3(2): 235-241.
|
| [6] |
Tseng CH.Response to letter to the editor on comments on use of metformin and risk of kidney cancer in patients with type 2 diabetes [J]. Eur J Cancer, 2016, 52(3): 19-25.
|
| [7] |
Kourelis TV, Siegel RD. Metformin and cancer: new applications for an old drug [J]. Med Oncol, 2012, 29(2): 1314-1327.
|
| [8] |
Nangia-Makker P, Yu Y, Vasudevan A, et al. Metformin: a potential therapeutic agent for recurrent colon cancer [J]. PLoS One, 2014, 9(1): e84369.
|
| [9] |
Mei ZB, Zhang ZJ, Liu CY,et al. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis [J]. PLoS One, 2014, 9(7): e91818.
|
| [10] |
He XK, Su TT, Si JM, et al. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis [J]. Medicine (Baltimore), 2016, 95(7): e2749.
|
| [11] |
Liu F, Yan L, Wang Z, et al. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis [J].Oncotarget, 2017, 8 (9): 16017-16026.
|
| [12] |
Nie Z, Zhu H, Gu M. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis [J]. Pharm Biol, 2016, 54(11): 2636-2642.
|
| [13] |
Rokkas T, Portincasa P. Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis [J]. Eur J Intern Med, 2016, 33: 60-66.
|
| [14] |
James D, Angela M, Ninah S, et al. Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus [J]. Gastroenterology, 2008, 135(6): 1914-1923.
|
| [15] |
Eddi R, Karki A, Shah A, et al. Association of type 2 diabetes and colon adenomas [J]. J Gastrointest Cancer, 2012, 43(1): 87-92.
|
| [16] |
Lee JH, Jeon SM, Hong SP, et al. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer [J]. Dig Liver Dis, 2012, 44(12): 1042-1047.
|
| [17] |
Wong P, Weiner MG, Hwang WT, et al. Insulin therapy and colorectal adenomas in patients with diabetes mellitus [J]. Cancer Epidemiol Biomarkers Prev, 2012, 21(10): 1833-1840.
|
| [18] |
Cho YH, Ko BM, Kim SH, et al. Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus?[J]. Intest Res, 2014, 12(2): 139-145.
|
| [19] |
Kim YH, Noh R, Cho SY, et al. Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes [J]. Intest Res, 2015, 13(2): 145-152.
|
| [20] |
Jain D, Chhoda A, Uribe J. Effect of Insulin and Metformin Combination Treatment on Colon Adenoma and Advanced Adenoma Among DM Ⅱ[J]. J Gastrointest Cancer, 2016, 47(4): 404-408.
|
| [21] |
Yang YX. Do diabetes drugs modify the risk of pancreatic cancer?[J]. Gastroenterology, 2009, 137(2): 412-415.
|
| [22] |
尚晨，龚凤英，王林. 肥胖相关黑棘皮病的发病机制 [J].国际内分泌代谢杂志, 2016, 36(6): 416-419.
|
| [23] |
Pawelczyk L, Spaczynski RZ, Banaszewska B,et al.Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome [J]. Eur J Obstet Gynecol Reprod Biol, 2004, 113(2): 209-213.
|
| [24] |
Nair V, Sreevalsan S, Basha R, et al.Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and ras activity in pancreatic cancer [J]. J Biol Chem, 2014, 289(40): 27692-27701.
|
| [25] |
Tan BK, Adya R, Chen J, et al. Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells [J]. J Clin Endocrinol Metab, 2011, 96(3): 808-816.
|
| [26] |
Kwan HT, Chan DW, Cai PC, et al. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/beta-catenin signaling activity [J]. PLoS One, 2013, 8(1): e53597.
|
| [27] |
Ben Sahra I, Laurent K, Loubat A, et al.The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J]. Oncogene, 2008, 27(25): 3576-3586.
|
| [28] |
Tomimoto A, Endo H, Sugiyama M, et al.Metformin suppresses intestinal polyp growth in ApcMin/＋ mice [J]. Cancer Science, 2008, 99(11): 2136-2141.
|
| [29] |
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies [J]. Lancet, 2008, 371(9612): 569-578.
|
| [30] |
Grenader T, Goldberg A, Shavit L. Metformin as an addition to conventional chemotherapy in breast cancer [J]. J Clin Oncol, 2009, 27(35): e259.
|
| [31] |
Song YK, Park YS, Seon CS, et al. Alcohol drinking increased the risk of advanced colorectal adenomas [J]. Intest Res, 2015, 13(1): 74-79.
|